These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38088576)

  • 1. Case-Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society's Cancer Prevention Study II LifeLink Cohort.
    Winquist A; Hodge JM; Diver WR; Rodriguez JL; Troeschel AN; Daniel J; Teras LR
    Environ Health Perspect; 2023 Dec; 131(12):127007. PubMed ID: 38088576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study.
    Troeschel AN; Teras LR; Hodge JM; Rodriguez J; Wang Y; Daniel J; Diver WR; Winquist A
    Environ Res; 2024 Oct; 259():119560. PubMed ID: 38971361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study.
    Rhee J; Chang VC; Cheng I; Calafat AM; Botelho JC; Shearer JJ; Sampson JN; Setiawan VW; Wilkens LR; Silverman DT; Purdue MP; Hofmann JN
    Environ Int; 2023 Oct; 180():108197. PubMed ID: 37741007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
    Wen X; Wang M; Xu X; Li T
    Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
    Hollister J; Caban-Martinez AJ; Ellingson KD; Beitel S; Fowlkes AL; Lutrick K; Tyner HL; Naleway AL; Yoon SK; Gaglani M; Hunt D; Meece J; Mayo Lamberte J; Schaefer Solle N; Rose S; Dunnigan K; Khan SM; Kuntz JL; Fisher JM; Coleman A; Britton A; Thiese MS; Hegmann KT; Pavuk M; Ramadan FA; Fuller S; Nematollahi A; Sprissler R; Burgess JL
    Environ Res; 2023 Dec; 239(Pt 1):117297. PubMed ID: 37816422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort.
    Birukov A; Andersen LB; Andersen MS; Nielsen JH; Nielsen F; Kyhl HB; Jørgensen JS; Grandjean P; Dechend R; Jensen TK
    Environ Int; 2021 Jun; 151():106442. PubMed ID: 33610053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.